Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.04 USD | -3.05% | -2.11% | +19.60% |
May. 15 | Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target | MT |
May. 09 | Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.60% | 763M | |
+18.48% | 125B | |
+13.81% | 109B | |
-3.60% | 24.74B | |
+2.71% | 22.67B | |
-9.95% | 18.14B | |
-41.48% | 16.67B | |
-12.34% | 16.64B | |
+0.20% | 13.45B | |
+22.28% | 11.32B |
- Stock Market
- Equities
- WVE Stock
- News Wave Life Sciences Ltd.
- SVB Securities Adjusts Price Target on WAVE Life Sciences to $3 From $7, Maintains Market Perform Rating